Blood thinner apixaban put to the test in patients over 80
NCT ID NCT04586972
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 23 times
Summary
This study looked at how safe and effective the blood thinner apixaban is in people aged 80 and older with atrial fibrillation (an irregular heartbeat). Researchers followed nearly 1,000 patients in French geriatric clinics and nursing homes to track bleeding events and strokes. The goal was to see if the standard dosing works well in this older, frailer group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NONVALVULAR ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Geriatric Department, Broca Hospital
Paris, IIe-de-France, 75013, France
Conditions
Explore the condition pages connected to this study.